LyGenesis
Jacqueline Jeha, MPH has a diverse and extensive work experience in the field of clinical operations and corporate development. Currently, they are the Director of Clinical Operations and Corporate Development at LyGenesis since July 2021. Prior to this role, Jacqueline worked at Karyopharm Therapeutics Inc., where they held multiple positions including Associate Director of Clinical Operations, Senior Clinical Project Manager, Clinical Project Manager, Senior Clinical Trial Manager, and Clinical Trial Manager from 2015 to 2021. Before joining Karyopharm Therapeutics, they worked at Shire Pharmaceuticals as a Senior Clinical Trial Transparency Associate, Clinical Trial Associate, and Clinical Documentation Specialist from 2011 to 2015. Jacqueline also has experience as a Clinical Trial Assistant at Pleiad Inc. in 2010 and as a Research Assistant at Providence Veteran Affairs Medical Center from 2008 to 2010.
Jacqueline Jeha, MPH completed their Bachelor of Science degree in Microbiology and Chemistry at the University of Rhode Island from 2004 to 2008. Jacqueline then pursued a Master of Public Health degree in Public Health at Brown University from 2010 to 2012.
This person is not in any teams
This person is not in any offices
LyGenesis
LyGenesis is a biotechnology company with an organ regeneration technology platform enabling a patient’s lymph nodes to be used as bioreactors to regrow functioning ectopic organs. LyGenesis’ lead preclinical program is focused on liver regeneration for patients with end-stage liver disease.